Development of cyclic peptides that can be administered orally to inhibit disease targets

Development of cyclic peptides that can be administered orally to inhibit disease targetsCyclic peptides can bind challenging disease targets, but their oral application is hindered by digestion and absorption issues.We developed a versatile method for the synthesis and functional screening of vast numbers of synthetic cyclic peptides and identified peptides with high inhibitory activity, stability and oral bioavailability in rats.